Quirante, Ginalyn .

HRN: 24-42-05  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2025
CEFUROXIME 1.5GM (VIAL)
05/24/2025
05/25/2025
IV
1.5g
Q8h X 3 Doses
S/p D&C
Remove - Pending Acceptance
05/24/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/24/2025
05/25/2025
IV
500 Mg
Q8h X 8 Doses
Sp D&C
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: